Ovid Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
CEOJeremy Max Levin
CEOJeremy Max Levin
Employees23
Employees23
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees23
Employees23
OVID Key Statistics
Market cap123.73M
Market cap123.73M
Price-Earnings ratio-2.94
Price-Earnings ratio-2.94
Dividend yield—
Dividend yield—
Average volume8.93M
Average volume8.93M
High today$1.88
High today$1.88
Low today$1.64
Low today$1.64
Open price$1.72
Open price$1.72
Volume5.02M
Volume5.02M
52 Week high$2.01
52 Week high$2.01
52 Week low$0.2425
52 Week low$0.2425
OVID News
Simply Wall St 5d
Ovid Therapeutics Is Up 6.4% After Positive Phase 1 Results for Drug-Resistant Epilepsy CandidateOvid Therapeutics recently announced positive topline results from its Phase 1 study of OV329, a next-generation GABA-aminotransferase inhibitor targeting drug-...
TipRanks 6d
Ovid Therapeutics prices private placement up to $175M in gross proceedsOvid Therapeutics (OVID) entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross pr...
TipRanks 6d
Ovid Therapeutics announces results for Phase 1 study of OV329Ovid Therapeutics (OVID) announced positive topline results from its Phase 1 healthy volunteer study evaluating the safety, tolerability, pharmacokinetic and ph...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.